Literature DB >> 28503933

Highly Human Immunodeficiency Virus-Exposed Seronegative Men Have Lower Mucosal Innate Immune Reactivity.

Jennifer A Fulcher1, Laura Romas2,3, Jennifer C Hoffman1, Julie Elliott4, Terry Saunders4, Adam D Burgener2,3,5, Peter A Anton4, Otto O Yang1.   

Abstract

Risk of HIV acquisition varies, and some individuals are highly HIV-1-exposed, yet, persistently seronegative (HESN). The immunologic mechanisms contributing to this phenomenon are an area of intense interest. As immune activation and inflammation facilitate disease progression in HIV-1-infected persons and gastrointestinal-associated lymphoid tissue is a highly susceptible site for transmission, we hypothesized that reduced gut mucosal immune reactivity may contribute to reduced HIV-1 susceptibility in HESN men with a history of numerous rectal sexual exposures. To test this, we used ex vivo mucosal explants from freshly acquired colorectal biopsies from healthy control and HESN subjects who were stimulated with specific innate immune ligands and inactivated whole pathogens. Immune reactivity was then assessed via cytokine arrays and proteomic analysis. Mucosal immune cell compositions were quantified via immunohistochemistry. We found that explants from HESN subjects produced less proinflammatory cytokines compared with controls following innate immune stimulation; while noninflammatory cytokines were similar between groups. Proteomic analysis identified several immune response proteins to be differentially expressed between HIV-1-stimulated HESN and control explants. Immunohistochemical examination of colorectal mucosa showed similar amounts of T cells, macrophages, and dendritic cells between groups. The results of this pilot study suggest that mucosal innate immune reactivity is dampened in HESN versus control groups, despite presence of similar densities of immune cells in the colorectal mucosa. This observed modulation of the rectal mucosal immune response may contribute to lower risk of mucosal HIV-1 transmission in these individuals.

Entities:  

Keywords:  HIV seronegativity; HIV transmission; innate immune response; mucosal immunology

Mesh:

Substances:

Year:  2017        PMID: 28503933      PMCID: PMC5564013          DOI: 10.1089/AID.2017.0014

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  42 in total

1.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers.

Authors:  J Lajoie; J Juno; A Burgener; S Rahman; K Mogk; C Wachihi; J Mwanjewe; F A Plummer; J Kimani; T B Ball; K R Fowke
Journal:  Mucosal Immunol       Date:  2012-02-08       Impact factor: 7.313

3.  Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.

Authors:  Vivek Naranbhai; Salim S Abdool Karim; Marcus Altfeld; Natasha Samsunder; Raveshni Durgiah; Sengeziwe Sibeko; Quarraisha Abdool Karim; William H Carr
Journal:  J Infect Dis       Date:  2012-07-24       Impact factor: 5.226

4.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

5.  Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection.

Authors:  Fransje A Koning; Sigrid A Otto; Mette D Hazenberg; Linda Dekker; Maria Prins; Frank Miedema; Hanneke Schuitemaker
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

6.  Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct.

Authors:  R Detels; D Mann; M Carrington; K Hennessey; Z Wu; K F Hirji; D Wiley; B R Visscher; J V Giorgi
Journal:  Immunol Lett       Date:  1996-06       Impact factor: 3.685

7.  Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.

Authors:  N F Bernard; C M Yannakis; J S Lee; C M Tsoukas
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

8.  Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.

Authors:  W C Goh; J Markee; R E Akridge; M Meldorf; L Musey; T Karchmer; M Krone; A Collier; L Corey; M Emerman; M J McElrath
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

9.  Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers.

Authors:  Terry Blake Ball; Hezhao Ji; Joshua Kimani; Paul McLaren; Crystal Marlin; Adrian V S Hill; Francis Allan Plummer
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

10.  Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition.

Authors:  Shehzad M Iqbal; Terry B Ball; Pauline Levinson; Lillian Maranan; Walter Jaoko; Charles Wachihi; Brian J Pak; Vladimir N Podust; Kristina Broliden; Taha Hirbod; Rupert Kaul; Francis A Plummer
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

View more
  4 in total

1.  Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4+ T lymphocytes.

Authors:  Sandra M Gonzalez; Wbeimar Aguilar-Jimenez; Edison Trujillo-Gil; Wildeman Zapata; Ruey-Chyi Su; T Blake Ball; Maria T Rugeles
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

2.  Inhibition of miR-155 Promotes TGF-β Mediated Suppression of HIV Release in the Cervical Epithelial Cells.

Authors:  Jyotsna Gokavi; Sharwari Sadawarte; Anant Shelke; Urmila Kulkarni-Kale; Madhuri Thakar; Vandana Saxena
Journal:  Viruses       Date:  2021-11-12       Impact factor: 5.048

3.  Calcitriol decreases HIV-1 transfer in vitro from monocyte-derived dendritic cells to CD4 + T cells, and downregulates the expression of DC-SIGN and SIGLEC-1.

Authors:  Natalia Alvarez; Sandra M Gonzalez; Juan C Hernandez; Maria T Rugeles; Wbeimar Aguilar-Jimenez
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

4.  Enhanced Signaling Through the TLR9 Pathway Is Associated With Resistance to HIV-1 Infection in Chinese HIV-1-Exposed Seronegative Individuals.

Authors:  Junjun Jiang; Xi Hu; Wenwei Li; Jie Liu; Bingyu Liang; Hui Chen; Jiegang Huang; Ning Zang; Chuanyi Ning; Yanyan Liao; Rongfeng Chen; Jingzhen Lai; Jiemei Chu; Peijiang Pan; Ping Cui; Qiao Tang; Xiu Chen; Hao Liang; Li Ye
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.